Results of genetic association studies in UC are conflicting. We propose th
at the power of candidate gene studies will increase when disease heterogen
eity is taken into account. Phenotype frequencies of molecularly defined HL
A-DR alleles, polymorphisms in the tumour necrosis factor-alpha (TNF-alpha)
, lymphotoxin-alpha (LT-alpha), IL-1 receptor antagonist (IL-1Ra) and IL-1
beta genes were determined in 98 clinically well characterized UC patients
with a mean period of follow up of 10 years, and ethnically matched healthy
controls (HC). The alleles HLA-DRB1*0103 (phenotype frequency 6% versus 0.
2%; P = 0.0002; odds ratio (OR) 27.6) and DRB1*15 (41% versus 26%; P = 0.00
1; OR = 2.0, compared with HC) were associated with overall disease suscept
ibility. Subgroup analysis revealed that DRB1*15 was only increased in fema
les (53% versus 24%; P < 0.0001; OR = 3.5), but not in males. With regard t
o disease localization, all DRB1*0103(+) patients had extensive disease (P
< 0.002; OR = 33.5), and DRB1*15 was found in 59% of females with extensive
colitis (P < 0.0001; OR = 4.4). DRB1*0103 was significantly increased in p
atients undergoing colectomy (P < 0.0002; OR = 84). No association between
overall disease susceptibility and the cytokine gene polymorphisms were fou
nd. Subgroup analysis revealed several significant associations, but most d
id not retain significance when corrected for multiple comparisons. However
, a noticeable finding was that haplotype TNF-C was significantly associate
d with progression in extent of disease (P = 0.003, OR = 20.4). This study
provides additional evidence for the role of DRB1 alleles in the susceptibi
lity to UC, and supports the hypothesis that these alleles may determine th
e severity of the disease. The cytokine gene polymorphisms evaluated in thi
s study do not seem to be strong risk factors for the overall disease susce
ptibility in UC, but may be involved in determining the severity of the dis
ease.